Rajesh Singh
10Patents
3h-index
11Co-inventors
57Inventor score
Filing activity: Mar 31, 2000 → Nov 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8568784B2 | Nanoparticles for delivery of active agents | Human Necessities | 78 | Active |
| US8658377B2 | Detecting cancer with anti-CCL25 and anti-CCR9 antibodies | Physics | 6 | Active |
| US8231907B2 | Nanoparticles for delivery of active agents | Human Necessities | 4 | Active |
| US8512701B2 | Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration | Chemistry; Metallurgy | 2 | Active |
| US9233120B2 | Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration | Chemistry; Metallurgy | 1 | Active |
| US10528688B1 | System and method for schematic-driven generation of input/output models | Physics | 1 | Active |
| US6602896B1 | p38MAPK inhibitor and uses thereof | Human Necessities | 0 | Expired |
| US8962030B2 | Nanoparticles for delivery of active agents | Human Necessities | 0 | Active |
| US10058093B2 | Nanoformulations for plants | Chemistry; Metallurgy | 0 | Active |
| US12116411B2 | Antibodies binding to human CD3 at acidic pH | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.